2004
DOI: 10.1117/12.537787
|View full text |Cite
|
Sign up to set email alerts
|

Photodynamic therapy and fluorescent diagnostics of skin cancer with radochlorine and photosense: comparing efficacy and toxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Moreover, chlorin e6 that plays a role of solubilizer of radachlorin, therefore, provides a better solubility in aqueous solution with a better self life that makes dilution of the drug as well as treatment in photodynamic therapy easier for clinicians . Therefore, this photosensitizer is studied widely and applied for tumor diagnosis as well as photodynamic therapy in recent years . Radachlorin‐mediated photodynamic therapy has been reported to have an anticancer efficacy in various malignancies like skin, lung, head and neck and thyroid cancer .…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, chlorin e6 that plays a role of solubilizer of radachlorin, therefore, provides a better solubility in aqueous solution with a better self life that makes dilution of the drug as well as treatment in photodynamic therapy easier for clinicians . Therefore, this photosensitizer is studied widely and applied for tumor diagnosis as well as photodynamic therapy in recent years . Radachlorin‐mediated photodynamic therapy has been reported to have an anticancer efficacy in various malignancies like skin, lung, head and neck and thyroid cancer .…”
Section: Introductionmentioning
confidence: 99%
“…46 Pharmacokinetic studies investigated the borders of tumor growth and the intensity of accumulation of radachlorin in 32 patients with BCC and the intensity of accumulation of Photosense in 81 patients. 47 The discrimination between normal and malignant tissues was done by spectral-fluorescent complex and spectra analyzer LESA-01 (He-Ne-laser, λ ¼ 633 nm). There was fluorescence from all tumors, and additional fluorescence zones were found, while a cytological confirmation of BCC was available in most cases.…”
Section: Pdd For Bccmentioning
confidence: 99%
“…The development of the He-Ne laser started as early as 1961. Since then it has been used in a great variety of applications such as medical lasers [1,2], laser measurements [3,4], laser holography [5] and laser spectroscopy [6] because of its low cost, long lifetime, simple structure and convenience in use. Recently, photodynamic therapy (PDT) of cancer has been given much attention [7].…”
Section: Introductionmentioning
confidence: 99%